

Daybreak Special: Ozempic isn't approved in India yet. We speak to someone who got it anyway
Aug 1, 2024
In this captivating discussion, Alifiya Khan, a health and education reporter at The Ken, dives into her personal quest for weight loss using Ozempic, despite its unapproved status in India. She shares her struggles with obesity and how social media's buzz around the drug has influenced many, including herself. The conversation touches on the controversial nature of Ozempic as a treatment versus a trendy weight-loss solution and the risks involved in procuring it from online sources. Alifiya’s journey highlights the deep, personal ramifications of the evolving obesity landscape.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Intro
00:00 • 2min
Ozempic: Culture and Controversy
01:44 • 19min
Cautious Considerations Before Starting Ozempic
20:18 • 2min
Navigating Ozempic Procurement in India
21:52 • 11min
Personal Journeys: Community Reflections on Ozempic
33:02 • 2min
Journey of Weight Loss with Ozempic: Early Results and Long-term Commitment
35:28 • 4min